Previous close | 1.0400 |
Open | 1.0700 |
Bid | 1.2500 |
Ask | 1.5300 |
Strike | 210.00 |
Expiry date | 2025-03-21 |
Day's range | 1.0400 - 1.0800 |
Contract range | N/A |
Volume | |
Open interest | 64 |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.